Biomica
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13 Gad Feinstein St, Park Rehovot, Centr...Phone Number
+972 89311900Website
www.biomicamed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Biomica
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology platform (CPB), licensed from Evogene. Biomica aims to identify and characterize disease-related microbiome entities and to develop novel therapeutics based on these understandings.Explore more
Biomica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biomica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Biomica had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Biomica has new funding data
Product Launch: Get notified when Biomica launches new products
Biomica, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Biomica
Check out if Biomica is spiking on competitors!
Earning: See what the market has to say on Biomica recently announced quarterly report
Check if Biomica has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Biomica
Find more new buyers
Company Profile Activity
Activity Insights
Biomica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biomica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biomica.
Biomica financials insights
Gather financial insights about Biomica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$20M
2023
Other Financing Round
$20M
2025
Other Financing Round
$20M
Biomica Tech Stack
A closer look at the technologies used by Biomica
Most Recent Scoops
Funding
Funding
Event
Events
Funding
Funding
Biomica News & Media
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it has closedBiomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting. REHOVOT, Israel, May 23, 2024 /PRNewswire/ -- Biomica Ltd., a...Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel, April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
REHOVOT, Israel, April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it will present results from pre-clinical studies...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biomica
Sign Up For FreeTo access detailed company insights
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology platform (CPB), licensed from Evogene. Biomica aims to identify and characterize disease-related microbiome entities and to develop novel therapeutics based on these understandings.... Read More
